Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARQT | AZN | AMGN | GILD | BMY |
| Company | Arcutis Biotherapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 21.28 | 182.99 | 332.45 | 134.68 | 56.22 |
| High | 21.42 | 183.43 | 332.84 | 134.84 | 56.22 |
| Low | 21.28 | 182.98 | 330.81 | 133.57 | 55.70 |
| Latest | 21.20 | 183.75 | 331.87 | 133.40 | 55.65 |
| Change | -0.04 | +1.89 | +2.28 | -0.12 | -0.02 |
| % Change | -0.19% | +1.04% | +0.69% | -0.09% | -0.04% |
| Volume | 1,275 | 40,034 | 7,233 | 19,597 | 76,860 |
| 20-Day Average Volume | 1,469,919 | 2,002,942 | 2,532,847 | 5,765,955 | 9,789,003 |
| Previous Close | 21.24 | 181.86 | 329.59 | 133.52 | 55.67 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 23.11 | 189.57 | 339.34 | 133.27 | 57.96 |
| 20-Day Raw Stochastic | 23.83% | 13.04% | 28.97% | 44.67% | 5.49% |
| 20-Day Relative Strength | 41.67 | 40.97 | 41.73 | 46.33 | 41.41 |
| Weighted Alpha | +26.94 | +25.94 | +16.31 | +25.02 | +18.17 |
| Today's Opinion | 56% Sell | 8% Sell | 8% Sell | 24% Buy | 24% Buy |
| Previous Opinion | 56% Sell | 8% Sell | 8% Sell | 8% Buy | 24% Buy |
| Last Month's Opinion | 8% Sell | 88% Buy | 40% Buy | 40% Buy | 48% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.56% since 05/05/26 | +1.14% since 05/05/26 | +0.45% since 05/05/26 | +0.08% since 05/05/26 | -2.19% since 05/05/26 |
| Low | 20.19 on 05/07/26 | 181.03 on 05/07/26 | 327.22 on 05/07/26 | 129.00 on 05/08/26 | 55.40 on 05/11/26 |
| High | 24.27 on 05/06/26 | 185.80 on 05/11/26 | 334.19 on 05/11/26 | 136.75 on 05/06/26 | 57.40 on 05/06/26 |
| 1-Month | |||||
| %Chg | -11.54% since 04/10/26 | -10.16% since 04/10/26 | -5.69% since 04/10/26 | -3.89% since 04/10/26 | -4.98% since 04/10/26 |
| Low | 20.19 on 05/07/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 25.47 on 04/14/26 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 141.40 on 04/14/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | -19.82% since 02/12/26 | -10.38% since 02/12/26 | -9.60% since 02/12/26 | -12.00% since 02/12/26 | -6.95% since 02/12/26 |
| Low | 20.19 on 05/07/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 28.80 on 02/26/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.95 on 02/13/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -8.68% since 11/12/25 | +4.53% since 11/12/25 | -1.55% since 11/12/25 | +8.26% since 11/12/25 | +13.49% since 11/12/25 |
| Low | 20.19 on 05/07/26 | 175.24 on 11/13/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 31.77 on 12/08/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,656,763 | 282,048,128 | 177,874,784 | 165,774,416 | 113,682,088 |
| Shares Outstanding, K | 125,083 | 1,550,908 | 539,685 | 1,241,570 | 2,042,071 |
| Annual Sales | 376,070,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -16,140,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 105,400,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -11,300,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.58 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.09 on 05/06/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 08/05/26 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.75 | 15.01 | 15.69 | 9.47 |